Triple Assessment Guideline (Tabbed version)

Description:

Publet Introduction:

Computerised decision support for the initial assessment of women referred to specialist breast units.
Triple assessment covers: imaging (typically mammography and ultrasound); clinical examination; pathology (needle sampling). Genetic risk assessment is also included in this application.

 Information
Guideline Objectives

The application includes decision support for four areas crucial to the evaluation of a patient attending a triple assessment clinic (for more information see the original triple assessment guideline). This application uses separate plans that are all active concurrently (a different implementation to the original triple assessment workflow which requires tasks to be completed sequentially).

Target SettingSecondary care
Target Users
  • Author
  • Release Date 13/02/2013
Overview
Provenance7.No provenance has been assigned (default value)
Management

The application includes decision support for four areas crucial to the evaluation of a patient attending a triple assessment clinic (for more information see the original triple assessment guideline). This application uses separate plans that are all active concurrently (a different implementation to the original triple assessment workflow which requires tasks to be completed sequentially).

Safety Case
Sources
References
  • NICE (Familial Breast Cancer guidelines);
  • BASO (Management of symptomatic breast disease in the UK, 1998);
  • NCCN (Breast Cancer Screening and Diagnosis);
  • SIGN (Breast Cancer in Women);
  • ACR (Appropriate imaging work-up of palpable breast masses; Appropriate imaging work-up of breast microcalcifications; Performance of diagnostic mammography; Performance of a breast ultrasound examination);
  • ASCO (Breast cancer surveillance, 1998);
  • NHSBSP (Breast cancer screening assessment;
  • Non-operative diagnostic procedures and reporting in breast cancer screening